Abstract
ObjectiveTo describe the use of topical difluprednate for the treatment of uveitic macular edema. DesignRetrospective review of 3 consecutive cases of uveitic macular edema. MethodsPatients were treated with topical difluprednate monotherapy. ResultsAll patients experienced complete resolution of uveitic macular edema within 2–4 weeks. We observed a statistically significant improvement in central subfield macular thickness (p = 0.04). There was an overall improvement in visual acuity, but this result was not statistically significant (p = 0.33). ConclusionsTopical difluprednate can be effective for uveitic macular edema. Further investigation of this therapy in prospective randomized controlled trials is warranted.
Sign-in/Register to access full text options 
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
